IMDEX Asia 2015 Attracts Strong International Interest

first_img April 22, 2015 Back to overview,Home naval-today IMDEX Asia 2015 Attracts Strong International Interest View post tag: Naval IMDEX Asia 2015 has attracted strong international interest from senior naval officials, maritime agencies and industry representatives who will converge at the Changi Exhibition Centre in Singapore from 19 to 21 May 2015.To date, Navy Chiefs from 15 countries such as Australia, Bangladesh, Brunei, Djibouti, Germany, Greece, Indonesia, Malaysia, Peru, Philippines, South Africa, Sweden, UAE, UK, Uruguay as well as the Indonesian Air Force Chief have confirmed their participation in IMDEX Asia 2015.The Warships Display at IMDEX Asia will feature 19 foreign warships from 12 navies, namely Australia (HMAS Perth), Bangladesh (BNS Dhaleshwari), Brunei (KDB Darussalam), China (CNS Yulin), India (INS Satpura and INS Kamorta), Indonesia (a frigate and a patrol craft), Korea (ROKS Incheon), Malaysia (KD Lekir) and Oman (Al-Ofouq-class patrol vessel built by Singapore’s very own ST Marine), Russia (Admiral Panteleyev, Pechenga and SB-522), Thailand (HTMS Krabi and P.G.M. 113), US (USS Fort Worth, USS Mustin and 1 submarine) and Singapore Police Coast Guard Craft (Mako Shark).This strong international participation underscores IMDEX Asia’s standing as Asia Pacific’s premier international maritime defence show. It also reflects growing opportunities in the region, which has become the world’s second largest naval market, after the United States of America. According to AMI International, the Asia Pacific region is expected to spend around US$200 billion on new ships and submarines by 2032, making up roughly 25 per cent of the global projected new ship market.Southeast Asia, in particular, is set to spend more than US$25 billion on new naval ships through 2031, with patrol vessels, frigates and amphibious ships making up the primary group of future new naval projects in the region.[mappress mapid=”15743″] View post tag: News by topic View post tag: IMDEX Asiacenter_img View post tag: 2015 View post tag: Navy IMDEX Asia 2015 Attracts Strong International Interest Share this articlelast_img read more


first_imgAt the recently held Bayonne Cal Ripken Baseball’s 20th awards ceremony, Joshua Fox was recognized for winning the Jim Burke Memorial Prep League MVP award. Joshua played for the M J Desmond’s team. Anyone with any questions about Cal Ripken Baseball, please contact Mike Miselis at [email protected] or call 201-436-8787 ×last_img

Lainox gets in faster lane

first_imgLainox Heart has launched a combi-oven range with three key functions.The ovens can be used via automatic and manual modes, and also have a USB connection, so recipes, programmes and software can be downloaded to the oven. The Lainox Heart offers a six-speed fan, Autoclima feature, which controls conditions and reheats refrigerated dishes, Fast Dry, which ensures foodstuffs and bakery products turn out fragrant and crisp, a PLUS function, which allows bakers to specify product finishes and an optional Washing Combi System.A new heat generation system offers reduced gas consumption and lower running costs, more steam and a double burner in gas versions for improved efficiency. Lainox says the new models are up to 40% faster at reaching and recovering working temperatures. The X and P models offer a variety of options to suit the customer.[]last_img read more

SBFD offering virtual tours of their environmentally-friendly stations on Earth Day

first_img WhatsApp Pinterest By 95.3 MNC – April 21, 2020 0 329 Twitter Previous articleGovernor Holcomb officially extends Stay-At-Home orderNext articleComplaint about noisy dog turns into stabbing 95.3 MNCNews/Talk 95.3 Michiana’s News Channel is your breaking news and weather station for northern Indiana and southwestern Michigan. South Bend Fire Engine 9 and Medic 9. (Mark McGill/95.3MNC) The South Bend Fire Department will celebrate Earth Day, on Wednesday, with virtual tours of their environmentally-friendly fire stations.The South Bend Fire Department sent the following information about the virtual tours to 95.3 MNC:The South Bend Fire Department invites residents to virtually tour Fire Station-4 on Olive Street in the Kennedy Park Neighborhood and Fire Station-9, located at 2108 Mishawaka Avenue in the River Park Neighborhood on Wednesday, April 22, at 11 a.m. and 1 p.m. respectively on Earth Day.To celebrate the 50th Anniversary of Earth Day in 2020, Fire Chief Carl Buchanon will offer a virtual tour showcasing Station 4 and 9 live on Facebook with interactions from the Firefighters who live and work at the two stations as well as citizens viewing the program.Two South Bend Fire Stations were designed and built using the green building rating system Leadership in Energy and Environmental Design. Achieving the silver status was the goal, and Fire Station 4 was granted gold, and Station 9 received silver. Construction utilized a zone concept in which toxins related to the job of firefighting are separated from the living quarters of the station.Fire Chief Carl Buchanon referenced, “the past designs of fire stations housed firefighters in order to complete tasks brought about from the job. Now, more than ever, we recognize as an organization the importance of sustainability and how our duties can have a direct impact on the environment. Highly efficient and safer fire apparatus protect our members to and from the call and our newer zone concept fire stations protect our men and women where they eat, sleep and live for 24 hours at a time.”The South Bend Fire Department hopes that residents can take a few minutes and enjoy Earth Day and witness how innovative designs with equipment and housing have a direct effect on our ecosystem and environment. Pinterest Facebook Twitter Google+ WhatsApp Google+ Facebook SBFD offering virtual tours of their environmentally-friendly stations on Earth Day IndianaLocalNewslast_img read more

Dilemmas of destiny

first_imgLila (the patient’s name has been changed) was only in her 20s when she learned that she could be at increased risk for breast cancer. A genetic test had revealed that her mother carried a mutation signaling a heightened risk for the disease. But Lila opted to live with uncertainty — and the hope it engendered — a little longer. She wouldn’t test, but she would be vigilant, opting for frequent mammograms.At age 34, Lila, now the mother of two small children, learned she had breast cancer. Personalizing her treatment would require genetic testing. This time she consented. The procedure verified the mutation and revealed another detail: Her tumor flourished with exposure to hormones.“She knew the mutation increased her risk for a second cancer, so she chose bilateral mastectomy,” says Judy Garber, a Harvard Medical School (HMS) associate professor of medicine at Dana–Farber Cancer Institute and Brigham and Women’s Hospital. But because the tumor was hormone-receptor-positive, Lila faced another decision: take drugs to cut her hormone levels, or have the source of those hormones, her ovaries, removed. She chose the surgery.Garber, who directs the Cancer Risk and Prevention Program at Dana–Farber, describes Lila’s decisions as aggressive for a young woman, even one burdened with a mutation promising a lifelong threat of cancer. Could her choices have been driven by her desire to remain a mother to her children for as long as possible?“Oh, of course,” says Garber, adding softly, “For young mothers, that’s often the issue.”Lila’s story underscores how genetic diseases thread throughout a family and how decisions made by individuals — to test, to treat, to disclose — are fraught with difficulties and emotions that can strain, and sometimes break, family ties. The reach of genetic diseases goes beyond the individual, often visiting ethical dilemmas upon a patient’s entire family.Over the past three decades, genetic testing and its offspring — personalized medicine — have matured; tests for more than a thousand diseases are now available. Yet while the ability to identify genetic signposts for patients allows doctors to recommend screening, offer preventive surgeries, and fine-tune drug treatments, that same ability delivers unsettling futures to those with genetic evidence of diseases that as yet have no cure, such as Huntington’s disease, cystic fibrosis, hemophilia, and Alzheimer’s disease.Often, patients and doctors become entangled in such issues as how to best share at-risk information, access treatment options, and weigh decisions about hidden threats to the young and unborn. And sometimes these issues mushroom, becoming quandaries for society as a whole.It’s a family affairPatients rely on physicians to deliver medical news directly and in confidence, good or bad. Medicine’s growing ability to plumb a person’s genetic information, however, can challenge this expectation.“People are accustomed to keeping some details private,” says Ting Wu, an HMS professor of genetics and director of the Personal Genetics Education Project. “But genetic information is explicit; it speaks to pedigree.”Wu notes that while patients might seek genetic testing as a means of customizing their treatment and prevention strategies, others — particularly at-risk family members — may be less amenable to testing and the possibility of news of an incurable condition.“Patients realize that information can sometimes be used in a way that hurts someone,” says Wu. “That possibility — and that fear — can present a slippery slope: The more we learn, the more information we have to use, properly or improperly.”How deeply those details penetrate family defenses can be found in a story Wu cites of a 23-year-old woman who chose to be tested for Huntington’s disease. The young woman’s grandfather had been ravaged by the rare brain disorder for three decades, a maternal aunt had tested positive for it, and she was now witnessing a cousin’s debilitation. Her mother, however, refused to test and became embattled with her daughter over the issue. Undeterred, the young woman went ahead with her plans. She learned she carried the gene — as did her mother, by implication. Her mother severed their ties, unable to forgive her daughter for inflicting upon them both what she viewed as future-robbing news.A fine lineKenneth Offit ’81, chief of the Clinical Genetics Service at New York City’s Memorial Sloan–Kettering Cancer Center, has seen the difficulties that disclosure can bring to families. “When it comes to handling the results of genetic testing,” he says, “health professionals must respect the boundaries imposed by the ethical practice of medicine by encouraging, but not coercing, patients to share their news with family members.” But when the patient can’t meet that responsibility, the custodianship of genetic information — and the duty to warn — may be left to the physician.“Two decades ago, a breast cancer patient we’d enrolled in a study of the genetic risks of certain cancers died before learning she had a mutation linked to her cancer,” Offit recalls. “We needed to tell her daughters of their own risk — but we didn’t know their locations.”Offit called the woman’s mother to explain his need to contact her granddaughters. She rejected his plea and ignored his follow-up letter. Years later, after she had died, the daughters found a letter that Offit had written — and showed up at his clinic. One daughter tested positive for the mutation and began regular screening.Offit once told this story to a group of lawyers to illustrate how he had tried to fulfill his duty to warn. Terse, unsettling comments followed. One lawyer chided him for failing to hire a private detective, find the daughters, and tell them their risks. Another frostily said she would have offered to represent the daughters should they have developed breast cancer before they were notified and elected to sue.Open housePhysicians aren’t the only ones tussling at the ethical edges of genetic testing. Patients, too, wrestle with such dilemmas. They share test results to warn siblings and cousins, help adult children make childbearing decisions, or explain their medical care to others. But patients also withhold information to avoid causing alarm and to notify only those relatives at greatest risk. Information sharing may hit additional barriers, both real and perceived, such as geographic distance, adoption, and stigma.Disclosure requires a middleman when the patient is very young. Parents must act on behalf of newborns, children, and adolescents whose genetic disorders may not manifest until adulthood. “We often avoid testing children unless it’s absolutely necessary,” says Joseph Thakuria, an HMS instructor and clinical geneticist at Massachusetts General Hospital. “We worry about how testing can negatively affect this population.”Thakuria, who trains medical students and house staff as well as genetic counselors, says that his worries about stigma and self-concept sometimes begin with the parents. “It’s not unusual for one to say to the other, ‘It’s from your side of the family.’ Usually it’s said half-jokingly, but I always try to nip that thought in the bud.”He does so by sharing a fact: We are all carriers. Geneticists estimate that each of us has 6 to 25 genes that, under the right conditions, could trigger a disorder or disease in a person or in his or her offspring. Understanding this helps move parents away from shock, guilt, and grief and into proactive postures, such as joining a support group, learning about treatments and interventions, and safeguarding their child’s quality of life.Protective servicesProtecting quality of life for all who undergo genetic testing has gained legal ground in recent years. Worries about institutional discrimination that might deny medical coverage, employment, and equitable access to the benefits of personalized medicine have been eased in the United States by provisions forged in the Genetic Information Nondiscrimination Act, or GINA, and in the recent health care reform legislation.Since 2008, GINA has accorded genetic information the same privacy protections that the Health Insurance Portability and Accountability Act, or HIPAA, has provided to medical data. GINA has also prohibited genetic discrimination by health insurers and employers.GINA does not, however, affect life, disability, or long-term care insurance. Nor does it prevent insurers from determining eligibility or rates based on a person’s gene-linked disease or disorder that has already manifested. And while GINA mandates payments for tests for mutations linked to diseases such as breast cancer and colon cancer, it doesn’t require coverage for preventive interventions.Health care reforms signed into law in 2010 may help flesh out just what personalized medicine can and can’t deliver. The reform act creates an independent Patient-Centered Outcomes Research Institute charged with examining the use and comparative effectiveness of medical products and services within groups differentiated along traditional lines — such as race, sex, and age — as well as new ones distinguished by genetic and molecular characteristics.Society’s acceptance of personal genomics will surface in its laws, says HMS geneticist Wu. Preimplantation genetic diagnosis, for example, which screens for genetic diseases in embryos used for in vitro fertilization, may come under scrutiny. Studies have found that parents see an advantage to this screening procedure if it means they can avoid receiving a prenatal diagnosis requiring them to consider terminating a pregnancy. But others fear that choosing an embryo based on its genetic makeup is mere prelude to selecting for gender, IQ, and eye color — in short, a slide toward eugenics.For Wu, education is the right response. “We need to understand the social, legal, and ethical outcomes of our decisions,” she says. “When we know the issues surrounding genetic testing, we’ll consider carefully before judging the decisions of others. For when we categorize others, we categorize ourselves.”Ann Marie Menting is associate editor of Harvard Medicine.last_img read more

University professor wins Luce Fellowship

first_imgAssociate professor of theology and peace studies at Notre Dame Fr. Emmanuel Katongle has been selected as a 2017-2018 Henry Luce III Fellow in Theology along with five other members of the Association of Theological Schools in the U.S. and Canada, the University announced in a press release Tuesday.According to the press release, Katongle will spend a year studying “ethnic, religious and ecological violence” in sub-Saharan Africa beginning in January 2018.“What is particularly exciting about this project is I’m studying … three types of violence together, and I’m making the argument that they are all connected,” Katongle said in the press release. “We are not talking about three forms of violence. We’re talking three manifestations of the same type of violence that is part of the crisis of belonging in modern Africa.”Katongle will use the research he conducts during his fellowship to write a book — “Who Are My People?” — that will explore the role Christianity plays in the violence he is researching. The press release said Katongle is hoping to find “excess of love” that counteracts this violence.“If I can trace this excess of love in these communities, what I would like to do is display it and show it as an invitation into which everyone is called,” he said in the press release. “ … God is peace. But what does that mean in the context of so much violence, suffering and the refugee crisis? I felt I could make a distinctive contribution to that conversation by adding a theological voice.”Tags: Luce Fellowship, Theologylast_img read more

Southern Tier Brewing Company Adds Pumking Whiskey To Seasonal Lineup

first_imgShare:Click to share on Facebook (Opens in new window)Click to share on Twitter (Opens in new window)Click to email this to a friend (Opens in new window) Image via Southern Tier Brewing Company / Facebook.LAKEWOOD – The Southern Tier Brewing Company is offering up another way to enjoy their seasonal favorite “Pumking” this fall.The company’s distillery has created a new Pumking Whiskey.They say the drink is made from a handcrafted whiskey with flavors of pumpkin pie spice, buttery cream and pie crust.The recipe, brewers say, is like pumpkin pie in a shot glass. The whiskey is currently available for sampling and purchase at The Empty Bottle, Southern Tier Distilling Company’s tasting room in Lakewood.The craft will also be on sale at Southern Tier’s retail partners this month and into early September.last_img read more

Vermont-based Vtrim secures funding, creates jobs

first_imgVtrim Healthy Weight Management is now positioned to take it’s science-based weight management program to the broader commercial market. Since raising $650,000 in capital, Vtrim CEO and Managing Director Krista M.C. Conley and her team have positioned Vtrim to be the leading online weight-loss treatment choice for individuals, families, and businesses seeking improved health and easier access to proven expert support.Based on over 30 years of research within the field of obesity treatment, Vtrim began as a University of Vermont study measuring the effectiveness of online weight loss programs. In January 2011, University of Vermont leadership and Conley signed an exclusive license agreement, opening the door for their academic, college-accredited program to reach the broader public. The new firm has created six management positions in Middlebury and will hire additional personnel in 2012.”Vtrim is a great example of the economic power of commercializing research developed at institutions like the University of Vermont,” said Lawrence Miller, Secretary of Commerce and Community Development. “By combining the power of entrepreneurship with solid academic research, we can look forward to creating many more opportunities within Vermont for businesses to grow and thrive.”  The company hopes that Vermont businesses will learn more about the Vtrim program, and set a national model for overweight and obesity reduction. “Vermont is not considered an overly obese state, but 59% of Vermonters are overweight or obese … obesity directly impacts health care costs and in our small state, 59% is too much. We want to improve Vermonters overall quality of life,” said Conley.”At this stage in the national obesity epidemic, it’s time for a program with proven effectiveness,” said Conley. “Vtrim is not about gimmicks or quick fixes, it’s about the fundamentals of each individual’s healthy weight.  Our expert facilitators help you understand, decode and repackage your attitudes about eating and exercise in a way that makes sense. Mobile phone applications are not a replacement for a learning environment with a seasoned instructor and other motivated peers.”Vermont angel investor and Vtrim alumnae Claudia K. Clark, and the Vermont Seed Capital Fund invested in the new commercial entity. “Proven programs for treating obesity and teaching wellness online are rare, said David Bradbury, manager of the Vermont Seed Capital Fund, LP.  “Vtrim is well positioned to be the first mover in online weight management.” The Vermont Seed Capital Fund, LP is managed by the non-profit Vermont Center for Emerging Technologies (VCET).(Vtrim® Healthy Weight Management uses expert facilitation to lead online classes. Highly trained facilitators, most of which are registered dietitians and registered nurses, complete a rigorous 45-hour training program. Closed-group classes meet online once per week for twelve weeks and are supported by interactive online journaling and a personalized graduated exercise program. Vtrim is the only online weight loss program to offer a follow-up course, Vtrim II, and an ongoing Maintenance Program. For more information visit is external) .)SOURCE Vtrim MIDDLEBURY, Vt., Oct. 5, 2011 /PRNewswire/ —last_img read more

Expert says late antiviral treatment may still help H5N1 patients

first_imgDec 12, 2006 (CIDRAP News) – A virologist who has treated H5N1 avian influenza patients in Vietnam said the antiviral drug oseltamivir may help avian flu patients even when started later than 2 days after illness onset—generally considered too late, according to a Reuters report today.The standard advice about oseltamivir for treatment of seasonal flu is that it can shorten the illness if it is started within 2 days after the first symptoms. But Menno de Jong of the Hospital for Tropical Diseases in Ho Chi Minh City said the drug seemed to help four of his patients even though it was started later.De Jong said the assumption that oseltamivir works only if started within 48 hours may be true only for human flu viruses. He said the H5N1 virus is known to continue replicating in humans on the seventh or eighth day of symptoms.”In my experience, there is a clear suggestion that there was still virus replication [when we made] a late start in treatment,” de Jong told Reuters at a conference in Singapore. “In four of my patients, there was very rapid clearance of the virus from the throat and all four survived.”De Jong told the conference audience, “If you can decrease the viral load [with drugs], you can have a good outcome. Even those who are treated late had good results.”But the report didn’t mention any other evidence that late treatment can work, besides de Jong’s anecdotal findings in a few of his own patients.De Jong, who treated 17 H5N1 patients in 2004 and 2005, of whom 12 died, agreed with other experts that starting treatment early is still best, Reuters reported.The United States and many other countries have been stockpiling oseltamivir in the face of the risk that avian flu will spark a pandemic. No one knows how effective the drug will be if the virus evolves into a pandemic strain.The World Health Organization (WHO) recommends oseltamivir as first-line treatment for H5N1 avian flu (with zanamivir [Relenza] as the second choice). The WHO guidelines do not say that treatment must be started within the first 2 days of illness to be effective.The US Centers for Disease Control and Prevention says oseltamivir and zanamivir have been shown to reduce the duration of seasonal flu by about 1 day, provided treatment is begun within 48 hours of the first symptoms.See also: WHO guidelines on pharmacologic management of patients infected with H5N1 read more

Check out Brisbane’s newly listed homes with character

first_imgPlenty of original character features were retained in this 29 Frith St, South Brisbane home. Picture: from newsCrowd expected as mega estate goes under the hammer7 Aug 2020Hard work, resourcefulness and $17k bring old Ipswich home back to life20 Apr 2020If a little closer to the CBD is more appealing this home at 29 Frith St, South Brisbane has plenty going for it.It has two-bedrooms and four bathrooms.The upstairs of the character home retains original features including ceiling roses, VJ panelling and polished, timber floor boards. 22 Windermere Crescent, Carindale. Picture: may be in different suburbs but the one thing these new hot listings have in common is they are all homes with character.This five-bedroom house at 22 Windermere Crescent, Carindale, is impressive in its street appeal and inside.There is a large fountain out the front of the home and once you enter the foyer it leads you through to living spaces or to the upper level.The home has a fully soundproofed karaoke/cinema room. 62 Marriott St, CoorparooIf it’s a brush with sporting fame you’re after and a huge family home to boot check out, 62 Marriott St, Coorparoo. The five-bedroom home is owned by former Brisbane Lions captain Michael Voss who has now moved with his family to South Australia.The five-bedroom home is on a large corner block and is ultra-private.It is designed in a U configuration around the pool.its best on a grand scale. Flawlessly designed in a classic ‘U’ configuration around the pool this spectacular home presents the ultimate in connection and privacy. The formal lounge and dining area have a wood fireplace, arched french windows and a chandelier.last_img read more